A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

NCT06175494 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

4800

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
BIOLOGICAL: Recombinant COVID-19 Variant Vaccine (Sf9 Cell)
BIOLOGICAL: Placebo

Sponsor

WestVac Biopharma Co., Ltd.

Collaborators

[object Object]